WEST SACRAMENTO, CA -- (MARKET WIRE) -- September 13, 2006 -- Lipomics Technologies, Inc., a privately held company that specializes in lipid metabolite analysis and interpretation, today announced that it has been competitively selected to receive a Phase II Small Business Technology Transfer Grant from the Department of Defense to improve the optimum fitness and performance of combat personnel. The study findings will be used to develop diagnostic tools that will evaluate an individual soldier’s readiness for training and predict the potential for injury during times of physical stress. The study findings will also be evaluated for their diagnostic potential in physical fitness programs of the general population.
